Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 486391, 7 pages
http://dx.doi.org/10.1155/2015/486391
Clinical Study

BRAF Testing in Multifocal Papillary Thyroid Carcinoma

1Department of Pathology and Laboratory Medicine, Tulane University, 1430 Tulane Avenue SL-79, New Orleans, LA 70112, USA
2Department of Mathematics, Tulane University, 6823 St. Charles Avenue, New Orleans, LA 70118, USA
3Department of Medicine, Tulane University, 1430 Tulane Avenue SL-12, New Orleans, LA 70112, USA
4Department of Surgery, Tulane University, 1430 Tulane Avenue SL-22, New Orleans, LA 70112, USA

Received 6 January 2015; Revised 3 March 2015; Accepted 8 March 2015

Academic Editor: Aurelio Ariza

Copyright © 2015 Hillary Z. Kimbrell et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Bansal, M. Gandhi, R. L. Ferris et al., “Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma,” The American Journal of Surgical Pathology, vol. 37, no. 10, pp. 1586–1591, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Giannini, C. Ugolini, C. Lupi et al., “The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 9, pp. 3511–3516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Jovanovic, B. Delahunt, B. McIver, N. L. Eberhardt, and S. K. G. Grebe, “Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone,” Journal of Pathology, vol. 215, no. 2, pp. 145–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Kuhn, L. Teller, S. Piana, J. Rosai, and M. J. Merino, “Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature,” Endocrine Pathology, vol. 23, no. 2, pp. 101–107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Lin, S. D. Finkelstein, B. Zhu, and J. F. Silverman, “Molecular analysis of multifocal papillary thyroid carcinoma,” Journal of Molecular Endocrinology, vol. 41, no. 3-4, pp. 195–203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. P. McCarthy, M. Wang, T. D. Jones, R. W. Strate, and L. Cheng, “Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas,” Clinical Cancer Research, vol. 12, no. 8, pp. 2414–2418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Moniz, A. L. Catarino, A. R. Marques, B. Cavaco, L. Sobrinho, and V. Leite, “Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation,” European Journal of Endocrinology, vol. 146, no. 1, pp. 27–33, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Y. Park, Y. J. Park, Y. J. Lee et al., “Analysis of differential BRAF V600E mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci,” Cancer, vol. 107, no. 8, pp. 1831–1838, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. T. M. Shattuck, W. H. Westra, P. W. Ladenson, and A. Arnold, “Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma,” The New England Journal of Medicine, vol. 352, no. 23, pp. 2406–2412, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Wang, H. Wang, X. Teng et al., “Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas,” Human Pathology, vol. 41, no. 9, pp. 1299–1309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Zheng, T. Xia, L. Lin et al., “BRAF V600E status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China,” World Journal of Surgical Oncology, vol. 10, article 104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. M. Xing, A. S. Alzahrani, K. A. Carson et al., “Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer,” Journal of the American Medical Association, vol. 309, no. 14, pp. 1493–1501, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. A. E. Walts, J. M. Mirocha, and S. Bose, “Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status,” Journal of Cancer Research and Clinical Oncology, 2015. View at Publisher · View at Google Scholar
  14. Y. E. Nikiforov, “Molecular diagnostics of thyroid tumors,” Archives of Pathology and Laboratory Medicine, vol. 135, no. 5, pp. 569–577, 2011. View at Google Scholar · View at Scopus
  15. Y. Y. Jung, J. H. Yoo, E. S. Park et al., “Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma,” Pathology—Research and Practice, vol. 211, pp. 162–170, 2015. View at Publisher · View at Google Scholar
  16. R. K. Virk, A. L. van Dyke, A. Finkelstein et al., “BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation,” Modern Pathology, vol. 26, no. 1, pp. 62–70, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. H. S. Min, C. Lee, and K. C. Jung, “Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population,” Journal of Korean Medical Science, vol. 28, no. 4, pp. 534–541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Y. Ahn, Y. J. Chung, B. S. Kim et al., “Clinical significance of the BRAF V600E mutation in multifocal papillary thyroid carcinoma in Korea,” Surgery, vol. 155, no. 4, pp. 689–695, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Li, K. C. Lee, E. B. Schneider, and M. A. Zeiger, “BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 12, pp. 4559–4570, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. P. Cheng, Y. C. Hsu, C. L. Liu et al., “Significance of allelic percentage of BRAF c.1799T > A (V600E) mutation in papillary thyroid carcinoma,” Annals of Surgical Oncology, vol. 21, no. 4, pp. 619–626, 2014. View at Publisher · View at Google Scholar
  21. D. de Biase, V. Cesari, M. Visani et al., “High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomas,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 8, pp. E1530–E1538, 2014. View at Publisher · View at Google Scholar
  22. G. Gandolfi, V. Sancisi, F. Torricelli et al., “Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progression,” The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 5, pp. E934–E942, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Guerra, M. R. Sapio, V. Marotta et al., “The primary occurrence of BRAFV600E is a rare clonal event in papillary thyroid carcinoma,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 2, pp. 517–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Guerra, L. Fugazzola, V. Marotta et al., “A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 7, pp. 2333–2340, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Huang, X. Tian, Y. Li, and F. Ji, “Clinical characteristics and surgical resection of multifocal papillary thyroid carcinoma: 168 cases,” International Journal of Clinical and Experimental Medicine, vol. 7, no. 12, pp. 5802–5807, 2014. View at Google Scholar
  26. H. Mazeh, Y. Samet, D. Hochstein et al., “Multifocality in well-differentiated thyroid carcinomas calls for total thyroidectomy,” The American Journal of Surgery, vol. 201, no. 6, pp. 770–775, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. K.-J. Kim, S.-M. Kim, Y. S. Lee, W. Y. Chung, H.-S. Chang, and C. S. Park, “Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients,” Annals of Surgical Oncology, vol. 22, no. 1, pp. 125–131, 2015. View at Publisher · View at Google Scholar